As of 2026-07-20, the Intrinsic Value of U.S. Physical Therapy Inc (USPH) is 103.64 USD. This USPH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 73.56 USD, the upside of U.S. Physical Therapy Inc is 40.90%.
The range of the Intrinsic Value is 67.76 - 211.19 USD
Based on its market price of 73.56 USD and our intrinsic valuation, U.S. Physical Therapy Inc (USPH) is undervalued by 40.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 67.76 - 211.19 | 103.64 | 40.9% |
| DCF (Growth 10y) | 92.11 - 267.50 | 136.27 | 85.3% |
| DCF (EBITDA 5y) | 35.69 - 110.74 | 65.53 | -10.9% |
| DCF (EBITDA 10y) | 57.87 - 148.67 | 92.89 | 26.3% |
| Fair Value | 11.41 - 11.41 | 11.41 | -84.49% |
| P/E | 55.66 - 83.37 | 70.73 | -3.8% |
| EV/EBITDA | 18.67 - 88.39 | 46.09 | -37.3% |
| EPV | 38.67 - 56.30 | 47.49 | -35.4% |
| DDM - Stable | 23.43 - 85.16 | 54.30 | -26.2% |
| DDM - Multi | 56.74 - 162.68 | 84.42 | 14.8% |
| Market Cap (mil) | 1,119.58 |
| Beta | 0.74 |
| Outstanding shares (mil) | 15.22 |
| Enterprise Value (mil) | 1,295.99 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.61% |
| Cost of Debt | 4.96% |
| WACC | 7.12% |